JP2005316967A - 電子カルテ装置 - Google Patents
電子カルテ装置 Download PDFInfo
- Publication number
- JP2005316967A JP2005316967A JP2005090560A JP2005090560A JP2005316967A JP 2005316967 A JP2005316967 A JP 2005316967A JP 2005090560 A JP2005090560 A JP 2005090560A JP 2005090560 A JP2005090560 A JP 2005090560A JP 2005316967 A JP2005316967 A JP 2005316967A
- Authority
- JP
- Japan
- Prior art keywords
- displayed
- input
- key
- screen
- display
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 164
- 239000000955 prescription drug Substances 0.000 claims description 5
- 229940126532 prescription medicine Drugs 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 4
- 229940079593 drug Drugs 0.000 description 80
- 238000007689 inspection Methods 0.000 description 70
- 238000003745 diagnosis Methods 0.000 description 46
- 208000027418 Wounds and injury Diseases 0.000 description 44
- 201000010099 disease Diseases 0.000 description 43
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 43
- 238000000034 method Methods 0.000 description 25
- 208000014674 injury Diseases 0.000 description 24
- 230000006378 damage Effects 0.000 description 23
- 238000010586 diagram Methods 0.000 description 22
- 206010052428 Wound Diseases 0.000 description 21
- 239000003607 modifier Substances 0.000 description 21
- 208000024891 symptom Diseases 0.000 description 21
- 238000012790 confirmation Methods 0.000 description 18
- 230000008569 process Effects 0.000 description 17
- 230000008859 change Effects 0.000 description 14
- 208000030090 Acute Disease Diseases 0.000 description 10
- 239000011230 binding agent Substances 0.000 description 10
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 208000017667 Chronic Disease Diseases 0.000 description 7
- 229940126675 alternative medicines Drugs 0.000 description 7
- 238000012937 correction Methods 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000037921 secondary disease Diseases 0.000 description 4
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000002059 diagnostic imaging Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- DZZWHBIBMUVIIW-DTORHVGOSA-N sparfloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F DZZWHBIBMUVIIW-DTORHVGOSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 229940001470 psychoactive drug Drugs 0.000 description 2
- 239000004089 psychotropic agent Substances 0.000 description 2
- 208000004124 rheumatic heart disease Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000011682 Mitral valve disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005090560A JP2005316967A (ja) | 2004-03-31 | 2005-03-28 | 電子カルテ装置 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004103583 | 2004-03-31 | ||
| JP2005090560A JP2005316967A (ja) | 2004-03-31 | 2005-03-28 | 電子カルテ装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005316967A true JP2005316967A (ja) | 2005-11-10 |
| JP2005316967A5 JP2005316967A5 (enExample) | 2006-01-19 |
Family
ID=35444277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005090560A Pending JP2005316967A (ja) | 2004-03-31 | 2005-03-28 | 電子カルテ装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005316967A (enExample) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007193520A (ja) * | 2006-01-18 | 2007-08-02 | Toshiba Corp | 薬剤変換システム |
| JP2008009517A (ja) * | 2006-06-27 | 2008-01-17 | Zoo Corp | 医薬品の販売支援システム、販売支援方法、及びプログラム |
| JP2008226123A (ja) * | 2007-03-15 | 2008-09-25 | Yuyama Manufacturing Co Ltd | レセプトチェック装置、レセプトチェック方法、プログラム、及び、記録媒体 |
| JP2011204194A (ja) * | 2010-03-26 | 2011-10-13 | Fancl Corp | サプリメント提供システム |
| JP2013178667A (ja) * | 2012-02-28 | 2013-09-09 | Yuyama Manufacturing Co Ltd | 電子カルテ装置、電子カルテシステム、電子カルテプログラム、電子カルテプログラムを記録したコンピュータ読み取り可能な記録媒体、処方参考量設定方法 |
| WO2014118886A1 (ja) * | 2013-01-29 | 2014-08-07 | テルモ株式会社 | 医療情報管理装置、医療情報管理システム及び医療情報管理装置の制御方法 |
| JP2016184301A (ja) * | 2015-03-26 | 2016-10-20 | パナソニックヘルスケアホールディングス株式会社 | 処方薬管理装置、処方薬管理方法、および、処方薬管理プログラム |
| CN111383726A (zh) * | 2018-12-28 | 2020-07-07 | 国家食品药品监督管理总局药品评价中心 | 电子病历数据处理方法、装置、电子设备及可读介质 |
| JP2021099580A (ja) * | 2019-12-20 | 2021-07-01 | 株式会社湯山製作所 | 業務支援システム、業務支援プログラム |
-
2005
- 2005-03-28 JP JP2005090560A patent/JP2005316967A/ja active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007193520A (ja) * | 2006-01-18 | 2007-08-02 | Toshiba Corp | 薬剤変換システム |
| JP2008009517A (ja) * | 2006-06-27 | 2008-01-17 | Zoo Corp | 医薬品の販売支援システム、販売支援方法、及びプログラム |
| JP2008226123A (ja) * | 2007-03-15 | 2008-09-25 | Yuyama Manufacturing Co Ltd | レセプトチェック装置、レセプトチェック方法、プログラム、及び、記録媒体 |
| JP2011204194A (ja) * | 2010-03-26 | 2011-10-13 | Fancl Corp | サプリメント提供システム |
| JP2013178667A (ja) * | 2012-02-28 | 2013-09-09 | Yuyama Manufacturing Co Ltd | 電子カルテ装置、電子カルテシステム、電子カルテプログラム、電子カルテプログラムを記録したコンピュータ読み取り可能な記録媒体、処方参考量設定方法 |
| WO2014118886A1 (ja) * | 2013-01-29 | 2014-08-07 | テルモ株式会社 | 医療情報管理装置、医療情報管理システム及び医療情報管理装置の制御方法 |
| JP2016184301A (ja) * | 2015-03-26 | 2016-10-20 | パナソニックヘルスケアホールディングス株式会社 | 処方薬管理装置、処方薬管理方法、および、処方薬管理プログラム |
| CN111383726A (zh) * | 2018-12-28 | 2020-07-07 | 国家食品药品监督管理总局药品评价中心 | 电子病历数据处理方法、装置、电子设备及可读介质 |
| CN111383726B (zh) * | 2018-12-28 | 2023-06-27 | 国家食品药品监督管理总局药品评价中心 | 电子病历数据处理方法、装置、电子设备及可读介质 |
| JP2021099580A (ja) * | 2019-12-20 | 2021-07-01 | 株式会社湯山製作所 | 業務支援システム、業務支援プログラム |
| JP7417057B2 (ja) | 2019-12-20 | 2024-01-18 | 株式会社湯山製作所 | 業務支援システム、業務支援プログラム |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4811383B2 (ja) | 電子カルテシステム | |
| Boockvar et al. | Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities | |
| Tolley et al. | Factors contributing to medication errors made when using computerized order entry in pediatrics: a systematic review | |
| Keshwani et al. | Buprenorphine use trends following removal of prior authorization policies for the treatment of opioid use disorder in 2 state Medicaid programs | |
| Markovic et al. | A comparison of medication histories obtained by a pharmacy technician versus nurses in the emergency department | |
| JP4955197B2 (ja) | レセプトファイル生成システム | |
| JP5279982B2 (ja) | 電子カルテ装置 | |
| JP4087873B2 (ja) | 電子カルテシステム | |
| JP5112457B2 (ja) | 処方チェック装置、及び、処方チェック方法 | |
| JP2005316967A (ja) | 電子カルテ装置 | |
| JP4786210B2 (ja) | 電子カルテ装置 | |
| JP4495431B2 (ja) | Ｉｃｄコード付与装置及び方法 | |
| JP4568006B2 (ja) | 電子カルテ装置 | |
| JP4462983B2 (ja) | 電子カルテ装置 | |
| Ly et al. | Changes in prescription drug and health care use over 9 years after the large drug price increase for colchicine | |
| JP2010044783A (ja) | Ｉｃｄコード付与装置 | |
| JP4653431B2 (ja) | 処方チェック装置 | |
| Ehringer et al. | Promoting best practice and safety through preprinted physician orders | |
| JP4601277B2 (ja) | 処方チェック装置 | |
| KR20060045399A (ko) | 전자 차트 장치 | |
| JP4497464B2 (ja) | 処方チェック装置、及び、処方チェック方法 | |
| KR20060045042A (ko) | 전자 카르테 장치 | |
| JP2001005903A (ja) | 電子式医療管理システム | |
| JP2005107604A (ja) | 処方入力装置 | |
| KR20060045395A (ko) | 전자 카르테 장치 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051122 |